Sodium (Elemental Na) vs. Vitamin K1 (Phylloquinone)
Comparing 2 standards across 10 specifications. 10 key differences identified.
Sodium is the principal extracellular cation (135–145 mEq/L extracellular), maintaining extracellular fluid volume, plasma osmolality, and driving secondary active transport. Adequate Intake (AI) is 1,500 mg/day, with a Chronic Disease Risk Reduction (CDRR) limit of 2,300 mg/day.
Vitamin K1 is a fat-soluble naphthoquinone synthesized by photosynthetic plants. Adequate Intake (AI) is 120µg (men) / 90µg (women), acting as an essential cofactor for gamma-glutamyl carboxylase in blood clotting and osteocalcin bone mineralization.
Specification Comparison Table
10 Parameters| Parameter / Spec | ||
|---|---|---|
|
Nutrient Type
|
Essential Macromineral / Major Extracellular Electrolyte | Fat-Soluble Naphthoquinone Vitamin |
|
Adult Adequate Intake (AI)
|
1,500 mg / day (Equal to 3.8 g table salt NaCl) | 120 µg / day (Men) / 90 µg / day (Women) |
|
Chemical Forms
|
Sodium Chloride (NaCl, 39.3% Na by weight), Monosodium Glutamate (MSG, 12.3% Na), Sodium Bicarbonate (27.4% Na) | Phylloquinone (K1 - Green Plants), Menaquinones (K2: MK-4, MK-7 - Ferments/Animal) |
|
Primary Biological Function
|
Extracellular fluid osmolality maintenance, Blood pressure / volume homeostasis, Action potential depolarization (voltage-gated Na+ channels), SGLT1 glucose cotransport | Gamma-glutamyl carboxylase cofactor (Factors II, VII, IX, X), Osteocalcin carboxylation, Matrix Gla Protein (MGP) vascular calcification inhibitor |
|
Deficiency Condition
|
Hyponatremia (Serum Na+ < 135 mmol/L): Cerebral edema, Nausea, Muscle cramps, Seizures, Coma (often exercise-associated from over-hydration) | Coagulopathy, Hemorrhage, Impaired bone density |
|
Top Whole Food Sources
|
Table Salt (NaCl), Cured Bacon, Soy Sauce, Parmigiano-Reggiano, Pickles, Olives, Bread (Processed food accounts for 70% of intake) | Spinach, Kale, Broccoli, Brussels Sprouts, Natto (K2 MK-7), Parsley |
|
Chronic Disease Limit (CDRR)
|
2,300 mg / day (Equal to 5.8 g table salt / 1 level teaspoon) | — |
|
Renal Renin-Angiotensin System
|
Juxtaglomerular apparatus senses low tubular sodium/pressure, secreting renin to stimulate aldosterone and renal Na+ reabsorption | — |
|
Tolerable Upper Limit (UL)
|
— | None Established (No adverse effects reported) |
|
Warfarin / Anticoagulant Interaction
|
— | Direct competitive antagonist to Coumadin/Warfarin (requires consistent daily intake) |